Gloria Reeves - Publications

University of Maryland School of Medicine, Baltimore, MD, United States 

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 dosReis S, Saini J, Hong K, Reeves G, Spence OM. Trends in antipsychotic use for youth with attention-deficit/hyperactivity disorder and disruptive behavior disorders. Pharmacoepidemiology and Drug Safety. PMID 35484637 DOI: 10.1002/pds.5445  0.354
2021 Akouri-Shan L, Schiffman J, Millman ZB, Demro C, Fitzgerald J, Rakhshan Rouhakhtar PJ, Redman S, Reeves GM, Chen S, Gold JM, Martin EA, Corcoran C, Roiser JP, Buchanan RW, Rowland LM, et al. Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking Youth. Schizophrenia Bulletin. PMID 34240217 DOI: 10.1093/schbul/sbab075  0.605
2019 Millman ZB, Gallagher K, Demro C, Schiffman J, Reeves GM, Gold JM, Rakhshan Rouhakhtar PJ, Fitzgerald J, Andorko ND, Redman S, Buchanan RW, Rowland LM, Waltz JA. Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms. Schizophrenia Research. PMID 30995969 DOI: 10.1016/J.Schres.2019.03.017  0.592
2018 Ross M, Nguyen V, Bridges JFP, Ng X, Reeves G, Frosch E, dosReis S. Caregivers' Priorities and Observed Outcomes of Attention-Deficit Hyperactivity Disorder Medication for Their Children. Journal of Developmental and Behavioral Pediatrics : Jdbp. 39: 93-100. PMID 29461996 DOI: 10.1097/Dbp.0000000000000530  0.367
2018 Waltz J, Demro C, Millman Z, Reeves G, Roiser J, Gold J, Schiffman J. 26.3 SALIENCE SIGNALING AND THE EMERGENCE OF PSYCHOPATHOLOGY IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOTIC ILLNESS Schizophrenia Bulletin. 44: S43-S43. DOI: 10.1093/Schbul/Sby014.108  0.536
2017 Demro C, Rowland L, Wijtenburg SA, Waltz J, Gold J, Kline E, Thompson E, Reeves G, Hong LE, Schiffman J. Glutamatergic metabolites among adolescents at risk for psychosis. Psychiatry Research. 257: 179-185. PMID 28772136 DOI: 10.1016/J.Psychres.2017.07.040  0.571
2016 dosReis S, Park A, Ng X, Frosch E, Reeves G, Cunningham C, Janssen EM, Bridges JF. Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis. Journal of Child and Adolescent Psychopharmacology. PMID 27991834 DOI: 10.1089/Cap.2016.0157  0.401
2016 Ng X, Bridges JF, Ross MM, Frosch E, Reeves G, Cunningham CE, dosReis S. A Latent Class Analysis to Identify Variation in Caregivers' Preferences for their Child's Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment? The Patient. PMID 27798814 DOI: 10.1007/S40271-016-0202-Z  0.331
2016 Ereshefsky S, Thompson E, Demro C, Wilson C, Jameson N, Bussell K, Rush C, Reeves G, Schiffman J. Social and role functioning in help-seeking youth with clinical-high risk, ADHD comorbidity, and history of psychostimulant exposure F1000research. 5. DOI: 10.7490/F1000Research.1113255.1  0.344
2016 Ross M, Kim H, Bridges J, Ng X, Frosch E, Reeves G, dosReis S. Initiating Medication To Treat Pediatric Attention-Deficit/Hyperactivity Disorder: A Best-Worst Scaling To Compare Caregivers’ And Clinicians’ Preferences Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.1337  0.348
2016 dosReis S, Ng X, Ross M, Frosch E, Reeves G, Bridges J. Preferences For Pediatric Attention-Deficit/Hyperactivity Disorder Management And Medication Changes And Caregiver-Reported Improvement Over A 6-Month Follow-Up Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.1335  0.319
2015 Waltz JA, Demro C, Schiffman J, Thompson E, Kline E, Reeves G, Xu Z, Gold J. Reinforcement Learning Performance and Risk for Psychosis in Youth. The Journal of Nervous and Mental Disease. PMID 26588080 DOI: 10.1097/Nmd.0000000000000420  0.592
2015 Ross M, Bridges JF, Ng X, Wagner LD, Frosch E, Reeves G, dosReis S. A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children. Psychiatric Services (Washington, D.C.). 66: 208-11. PMID 25642618 DOI: 10.1176/Appi.Ps.201300525  0.332
2015 Thompson E, Kline E, Ellman LM, Mittal V, Reeves GM, Schiffman J. Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis. Schizophrenia Research. 162: 79-85. PMID 25638728 DOI: 10.1016/J.Schres.2015.01.023  0.321
2015 Ng X, Bridges JF, Ross MM, Frosch EJ, Reeves GM, dosReis S. Caregivers’ preferences for treatment options in Attention Deficit Hyperactivity Disorder (ADHD): a latent class analysis Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.717  0.4
2012 Schweitzer JB, Fassbender C, Lit L, Reeves GM, Powell SP. Attention-deficit/hyperactivity disorder. Handbook of Clinical Neurology. 106: 391-405. PMID 22608633 DOI: 10.1016/B978-0-444-52002-9.00022-X  0.643
2011 Fassbender C, Schweitzer JB, Cortes CR, Tagamets MA, Windsor TA, Reeves GM, Gullapalli R. Working memory in attention deficit/hyperactivity disorder is characterized by a lack of specialization of brain function. Plos One. 6: e27240. PMID 22102882 DOI: 10.1371/Journal.Pone.0027240  0.623
2004 Reeves G, Schweitzer J. Pharmacological management of attention-deficit hyperactivity disorder. Expert Opinion On Pharmacotherapy. 5: 1313-20. PMID 15163276 DOI: 10.1517/14656566.5.6.1313  0.626
Show low-probability matches.